Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the effect of menopausal hormone replacement therapy on urinary incontinence?

Nature Clinical Practice Urology volume 2, pages 328–329 (2005)Cite this article

boxed-textHendrix SL et al. (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293: 935–948

The decision to use menopausal hormone replacement therapy in the treatment of urogenital symptoms and urinary incontinence should be made on a patient-by-patient basis

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Abrams P et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37–49

    Article  Google Scholar 

  2. Grady D et al. (2001) Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 97: 116–120

    CAS  PubMed  Google Scholar 

  3. Grodstein F et al. (2004) Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 103: 254–260

    Article  CAS  Google Scholar 

  4. Goldstein SR et al. (2005) Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause 12: 160–164

    Article  Google Scholar 

  5. Cardozo L et al. (2004) A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 83: 892–897

    Article  Google Scholar 

  6. Smith PG and Bradshaw S (2004) Innervation of the proximal urethra of ovariectomized and estrogen-treated female rats. Histol Histopathol 19: 1109–1116

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Urology and Obstetrics and Gynecology and Director of Female Urology and Voiding Dysfunction,

    David R Staskin & Renuka Tyagi

  2. Assistant Professor of Urology and Obstetrics and Gynecology at Weill Medical College of Cornell University, New York, NY, USA

    David R Staskin & Renuka Tyagi

Authors
  1. David R Staskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renuka Tyagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David R Staskin.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staskin, D., Tyagi, R. What is the effect of menopausal hormone replacement therapy on urinary incontinence?. Nat Rev Urol 2, 328–329 (2005). https://doi.org/10.1038/ncpuro0248

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0248

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing